Skip to content
TirzepatideReport

Tracked provider

MyStart Health tirzepatide review

One all-inclusive $299 that is price-locked against dose escalation — the whole proposition is that it does not move.

This is a tracked entry: the facts below are what MyStart Health publishes about itself, recorded and re-checked as part of the board we maintain (last checked 2026-07-14). Our hand-written reviews go deeper on the programs people ask about most. Prices change — confirm on MyStart Health's own site before you pay.

What it costs

Tirzepatide
$299/month all-inclusive, price-locked so the rate does not rise as the dose escalates
What is dispensed
Compounded tirzepatide
Who compounds it
503A

How the program works

A Delaware management-services organisation partnering with licensed US clinicians, selling one number: $299 a month covering medication, clinician access and unlimited messaging, with an explicit price-lock so titrating from 2.5 mg to 15 mg does not change the bill. Onboarding is fast — roughly a five-minute intake, a prescription inside 24 hours, and two-to-four-day shipping — and the site carries a clear Section 503A compounding disclosure on every landing page plus a LegitScript certification. The weaknesses are the ones that come with a company incorporated in May 2024: a thin track record, an unaccredited BBB file, and compounding partners it will not name.

What we like

  • A genuine price lock — the $299 base rate is contractually held as your dose escalates, not just advertised as flat
  • LegitScript certified, with a clear Section 503A compounding disclosure on every landing page
  • Unlimited clinician messaging and 24/7 care-team access folded into the single price
  • Fast path from intake to delivery — roughly five minutes to apply, 24 hours to a prescription, two to four days to the door

The caveats

  • Incorporated in May 2024, so there is very little operating history to judge it on
  • Not BBB accredited, carrying a C+ rating with complaints concentrated on shipping delays and support access
  • Compounding pharmacy partners are not named, so the 503A claim cannot be independently checked
  • Compounded only — no path to FDA-approved Zepbound or Mounjaro if you decide you want the brand
  • Per-drug tier pricing sits behind the intake quiz

Ready to look at MyStart Health directly? The link below is tracked so we can see it worked; it goes to their own site.

Visit MyStart Health

Advertising disclosure — some, not all, of the providers ranked here are partners, and we may earn a commission at no additional cost to you. The prices and facts we report come from each provider's own published program. Full disclosure.

Other tirzepatide programs we track

← Every provider review